Featured Posts
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing.
Blog
The unseen costs of banning PBM-owned pharmacies in Tennessee
Tennessee lawmakers recently passed the FAIR Rx Act, which would bar companies from owning pharmacies while also operating a pharmacy benefit manager (PBM)…
Search Posts
Op-Eds
Supporting a Risky Water Policy
As <?xml:namespace prefix = st1 ns = “urn:schemas-microsoft-com:office:smarttags” />U.S. environmentalists push policies to phase out use of chlorine gas at water-treatment plants, humanitarians…
Study
Spam, That Ill O’ The ISP
Full Document Available in PDF Most public attention has been focused on…
Op-Eds
Time for the GM Moratorium to Go
After months of anticipation, the U.S. government is expected to file a formal complaint today with the World Trade Organization against the European Union’s five-year…
News Release
Biotech Trade Challenge a Boon for Developing World
Washington, D.C., May 13, 2003—The Competitive Enterprise Institute applauds today’s announcement by the Office of the U.S. Trade Representative that it, along with Canada, Argentina,…
News Release
Scientists Urge European Union to End Biotech Food Ban
Contact for Interviews: <?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” /> Richard Morrison, 202.331.2273 <?xml:namespace prefix…
Op-Eds
Utopian Policymaking: The Inherent Dangers of “Inherently Safer Technology”
What would you say if the federal government proposed phasing out large commercial airplanes? After all, they could argue that using only small planes with…